Whole‐body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split‐body randomized controlled trial
Photodermatology, Photoimmunology & Photomedicine · 2024
DOI: 10.1111/phpp.12960 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, 2024. Verfasst von Anish Thind und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Vitiligo, Ultraviolet Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Narrowband ultraviolet B (NB‐UVB) phototherapy promotes stability and repigmentation in vitiligo. No studies have compared targeted NB‐UVB with whole‐body NB‐UVB in treatment of acral vitiligo.
Objectives
This randomized split‐body study compared whole‐body NB‐UVB with targeted NB‐UVB in inducing stability and repigmentation in acral vitiligo.
Methods
Thirty‐two patients with bilaterally symmetrical acral vitiligo lesions (distal to elbows and knees) were recruited. Patients received whole‐body NB‐UVB treatment, with one hand and one foot shielded until elbow and knee, followed by targeted NB‐UVB treatment on the shielded side. Patients were assessed at 4‐week intervals for 24 weeks using Vitiligo Disease Activity (VIDA) score, Vitiligo Skin Activity Score (VSAS), Vitiligo Area Scoring Index (determined through fingertip method, using the method to calculate facial‐VASI) and degree of repigmentation.
Results
After 12 weeks, 87.5% of patients achieved a VIDA score of 3, with none having active disease at 24 weeks. Over 50% repigmentation was observed in 42.2% and 37.5% of limbs in whole‐body and targeted groups, respectively ( p = .95). No improvement in F‐VASI scores of hands and feet (distal to wrist and ankles) was noted with either modality over the 24‐week period.
Conclusion
Our study showed comparable repigmentation rates between whole‐body and targeted NB‐UVB groups. Limited effectiveness of phototherapy in repigmentation of hands and feet underscores an important therapeutic gap.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
ORCID-Profile: Anish Thind, Keshavamurthy Vinay
Zitieren
APA
Thind, A., Vinay, K., Mehta, H., Bishnoi, A., Kumaran, M. S., & Parsad, D. (2024). Whole‐body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split‐body randomized controlled trial. Photodermatology, Photoimmunology & Photomedicine. https://doi.org/10.1111/phpp.12960
Vancouver
Thind A, Vinay K, Mehta H, Bishnoi A, Kumaran MS, Parsad D. Whole‐body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split‐body randomized controlled trial. Photodermatology, Photoimmunology & Photomedicine. 2024. doi:10.1111/phpp.12960
BibTeX
@article{Thind2024,
author = {Thind, Anish and Vinay, Keshavamurthy and Mehta, Hitaishi and Bishnoi, Anuradha and Kumaran, Muthu Sendhil and Parsad, Davinder},
title = {Whole‐body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split‐body randomized controlled trial},
journal = {Photodermatology, Photoimmunology & Photomedicine},
year = {2024},
doi = {10.1111/phpp.12960}
}
EUVIMED